The Connection Between Patent Foramen Ovale and Migraine.Neuroimaging Clin N Am. 2019 May; 29(2):261-270.NC
Abstract
"Observational studies have identified a relationship between patent foramen ovale (PFO) and migraine headache. In people who have migraine with aura, 40% to 60% have a PFO, compared with 20% to 30% in the general adult population. It is hypothesized that migraine, especially migraine with aura, may be triggered by hypoxemia or vasoactive chemicals (eg, serotonin), which are ordinarily metabolized during passage through the lungs. Although PFO closure is currently not a FDA-approved therapy for migraines, randomized trials suggest that this intervention may benefit a subgroup of migraineurs."
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
30926116
Citation
Kumar, Preetham, et al. "The Connection Between Patent Foramen Ovale and Migraine." Neuroimaging Clinics of North America, vol. 29, no. 2, 2019, pp. 261-270.
Kumar P, Kijima Y, West BH, et al. The Connection Between Patent Foramen Ovale and Migraine. Neuroimaging Clin N Am. 2019;29(2):261-270.
Kumar, P., Kijima, Y., West, B. H., & Tobis, J. M. (2019). The Connection Between Patent Foramen Ovale and Migraine. Neuroimaging Clinics of North America, 29(2), 261-270. https://doi.org/10.1016/j.nic.2019.01.006
Kumar P, et al. The Connection Between Patent Foramen Ovale and Migraine. Neuroimaging Clin N Am. 2019;29(2):261-270. PubMed PMID: 30926116.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The Connection Between Patent Foramen Ovale and Migraine.
AU - Kumar,Preetham,
AU - Kijima,Yasufumi,
AU - West,Brian H,
AU - Tobis,Jonathan M,
PY - 2019/3/31/entrez
PY - 2019/3/31/pubmed
PY - 2020/1/1/medline
KW - Migraine headache
KW - Patent foramen ovale
KW - Right-to-left shunt
SP - 261
EP - 270
JF - Neuroimaging clinics of North America
JO - Neuroimaging Clin N Am
VL - 29
IS - 2
N2 - "Observational studies have identified a relationship between patent foramen ovale (PFO) and migraine headache. In people who have migraine with aura, 40% to 60% have a PFO, compared with 20% to 30% in the general adult population. It is hypothesized that migraine, especially migraine with aura, may be triggered by hypoxemia or vasoactive chemicals (eg, serotonin), which are ordinarily metabolized during passage through the lungs. Although PFO closure is currently not a FDA-approved therapy for migraines, randomized trials suggest that this intervention may benefit a subgroup of migraineurs."
SN - 1557-9867
UR - https://www.unboundmedicine.com/medline/citation/30926116/full_citation
DB - PRIME
DP - Unbound Medicine
ER -

